BRIEF published on 05/13/2025 at 07:35, 7 months 1 day ago Sensorion Announces Approval of Shareholders’ Meeting Resolutions Biotechnology Gene Therapy Shareholder Resolutions Sensorion Hearing Loss Therapy
PRESS RELEASE published on 05/13/2025 at 07:30, 7 months 1 day ago Informations privilégiées / Autres communiqués Sensorion publie les résultats de l’AGM avec adoption de toutes les résolutions recommandées par le CA. Détails des votes disponibles en ligne Biotechnologie Résultats Assemblée Générale Mixte Sensorion Thérapie Auditive
PRESS RELEASE published on 05/13/2025 at 07:30, 7 months 1 day ago Inside Information / Other news releases Sensorion announces successful adoption of all resolutions at Combined General Meeting. Results available on company's website Biotechnology Resolutions Combined General Meeting Sensorion Hearing Loss
BRIEF published on 05/06/2025 at 07:35, 7 months 8 days ago Sensorion présentera à la réunion annuelle de l'ASGCT Thérapie Génique Sensorion Perte Auditive DFNB1A Réunion De L'ASGCT
BRIEF published on 05/06/2025 at 07:35, 7 months 8 days ago Sensorion to Present at ASGCT Annual Meeting Gene Therapy Sensorion Hearing Loss ASGCT Meeting DFNB1A
PRESS RELEASE published on 05/06/2025 at 07:30, 7 months 8 days ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la conférence annuelle de l'ASGCT pour présenter ses avancées en thérapie génique et cellulaire pour la surdité. Détails des posters et programme de développement dévoilés Innovation Thérapie Génique ASGCT Sensorion Perte Auditive
PRESS RELEASE published on 05/06/2025 at 07:30, 7 months 8 days ago Inside Information / Other news releases Sensorion announces participation at ASGCT Annual Meeting to present gene therapy research for hearing loss. Company focuses on developing innovative therapies. ASGCT 28th meeting details included Research Gene Therapy ASGCT Sensorion Hearing Loss
BRIEF published on 04/25/2025 at 07:35, 7 months 19 days ago Présentation de Sensorion sur la thérapie génique lors de la réunion annuelle de l'ASPO 2025 Essai Clinique Thérapie Génique Perte Auditive SENS-501 Oto-rhino-laryngologie Pédiatrique
BRIEF published on 04/25/2025 at 07:35, 7 months 19 days ago Sensorion's Gene Therapy Presentation at 2025 ASPO Annual Meeting Gene Therapy Clinical Trial Hearing Loss SENS-501 Pediatric Otolaryngology
PRESS RELEASE published on 04/25/2025 at 07:30, 7 months 19 days ago Inside Information / Other news releases Sensorion announces Pr. Natalie Loundon presenting at 2025 ASPO Annual Meeting on SENS-501 gene therapy for hearing loss in children with DFNB9, Audiogene trial details and Sensorion's focus on developing therapies for hearing loss disorders Gene Therapy Sensorion Hearing Loss Audiogene Trial Pr. Natalie Loundon
Published on 12/13/2025 at 02:00, 1 day 6 hours ago Battery X Metals Announces Confidential Submission of Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 12/13/2025 at 00:13, 1 day 7 hours ago Prospect Ridge Announces Non-Brokered Private Placement
Published on 12/12/2025 at 23:05, 1 day 8 hours ago ReelTime's RLTR Stock Surges Past AI Giants Following LG Smart TV Debut of Reel Intelligence
Published on 12/12/2025 at 17:00, 1 day 15 hours ago From Demonstration to Integration: How Sectors Actually Adopt SMX Technology
Published on 12/13/2025 at 19:57, 12 hours 5 minutes ago The Payments Group Holding identifies business activity fields and investment opportunities in AI company building and the biotech sector
Published on 12/13/2025 at 17:00, 15 hours 3 minutes ago Tapping into "Urban Oilfield": Unlocking the Value of Waste Plastic Film
Published on 12/13/2025 at 11:20, 20 hours 43 minutes ago Official streaming platform for the Games of the Future Abu Dhabi 2025 powered by ADNOC launches ahead of opening competition
Published on 12/13/2025 at 04:15, 1 day 3 hours ago M7 World Championship unveils first Opening Ceremony, tournament draw, and M7 Pass—elevates Indonesia on global stage
Published on 12/12/2025 at 21:18, 1 day 10 hours ago EQS-Adhoc: 029 Group SE: Successful completion of two strategic transactions
Published on 12/12/2025 at 18:00, 1 day 14 hours ago Disclosure of trading in own shares between November 24th and November 28th, 2025
Published on 12/12/2025 at 18:00, 1 day 14 hours ago Déclaration des transactions sur actions propres réalisées du 24 novembre au 28 novembre 2025
